BioCardia, Inc.BCDANASDAQ
Loading
Year-over-year SG&A expense growth
Latest
56.57%
↑ 134% vs avg
Percentile
P95
Near historical high
Streak
1 qtr
Consecutive growthStable
Average
24.21%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 56.57% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | -100.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | -100.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | -100.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | -100.00% |
| Q1 2020 | 23.08% |
| Q4 2019 | 0.36% |
| Q3 2019 | -3.34% |
| Q2 2019 | -11.83% |
| Q1 2019 | 13.11% |
| Q4 2018 | 12.39% |
| Q3 2018 | -3.17% |
| Q2 2018 | -22.38% |
| Q1 2018 | 1.19% |
| Q4 2017 | 27.61% |
| Q3 2017 | -16.43% |
| Q2 2017 | -12.31% |
| Q1 2017 | -49.79% |
| Q4 2016 | 848.02% |
| Q3 2016 | 457.35% |
| Q2 2016 | 0.00% |
| Q1 2016 | 47.83% |